SomaLogic, Inc.

NASDAQ:SLGC

2.1 (USD) • At close January 5, 2024
Bedrijfsnaam SomaLogic, Inc.
Symbool SLGC
Munteenheid USD
Prijs 2.1
Beurswaarde 396,225,917
Dividendpercentage 0%
52-weken bereik 1.73 - 3.79
Industrie Health Information Services
Sector Healthcare
CEO Mr. Adam Taich
Website https://www.somalogic.com

An error occurred while fetching data.

Over SomaLogic, Inc.

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification

Vergelijkbare Aandelen

Innoviva, Inc. logo

Innoviva, Inc.

INVA

20.18 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

3.08 USD

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

5.82 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

30.84 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Celularity Inc. logo

Celularity Inc.

CELU

3.55 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

59.06 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

72.53 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

0.767 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)